Piero Rinaldo, M.D., Ph.D., Big Data Presentation Considered Top Highlight at AACC 2014

Piero Rinaldo, M.D., Ph.D., in the Biochemical Genetics Laboratory at Mayo Clinic.
Piero Rinaldo, M.D., Ph.D., in the Biochemical Genetics Laboratory at Mayo Clinic.

A recent article in European Hospital touched on the top highlights from the 2014 AACC Annual Meeting & Clinical Lab Expo in Chicago, Ill. The article featured various topics presented at the meeting, including research on a portable blood test that detects low levels of Ebola and research that could lead to a treatment to halt or slow Alzheimer’s.

The article also highlighted Mayo Clinic's Piero Rinaldo, M.D., Ph.D., for his discussion on how big data can help to avoid false positives in newborn screening, thus preventing unnecessary or even harmful medical treatment.

Dr. Rinaldo and Kaitlyn Bloom, a Clinical Biochemical Genetics fellow at The Children’s Hospital in Philadelphia, presented theplenary session, “Newborn Screening For Inborn Errors of Metabolism In the 21st Century.” The presentation focused on new world-wide data sets, how result interpretation has improved considerably as the science advances, and the critical role new research will play in the continued advancements in newborn screening. The presentation was capped off by a patient, who described how newborn screen affected her life.

Kelley Luedke (@kschrib)

Kelley Luedke

Kelley Luedke is a Marketing Channel Manager at Mayo Clinic Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her kitty, and exploring new foods.